THIS PAGE IS INTENDED FOR UK PATIENTS WHO HAVE BEEN PRESCRIBED COMBISAL®

About

Combisal® Patient Information

This link will take you to the electronic Medicines Compendium (eMC) website.

By using the links below you will leave the Combisal® website and be re-directed to an external site; Aspire Pharma is not responsible for the content on external websites.

view patient information

Combisal® Summary of Product Characteristics

These links will take you to the electronic Medicines Compendium (eMC) website.

By using the links below you will leave the Combisal® website and be re-directed to an external site; Aspire Pharma is not responsible for the content on external websites.

Combisal® 25µg/50µg metered dose inhaler

Visit the eMC

Combisal® 25µg/125µg metered dose inhaler

Visit the eMC

Combisal® 25µg/250µg metered dose inhaler

Visit the eMC
Reporting of Side Effects
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible side effects not listed in the product’s package leaflet.
You can also report side effects directly via the Yellow Card Scheme at:

By reporting side effects, you can help provide more information on the safety of this medicine.www.mhra.gov.uk/yellowcard

COM1010422C1_JAN2023